Market Access Views & Analysis

Views & Analysis

Oncology

Close-up of East and Southeast Asia in the colorful world map.

Country focus: China & APAC’s growing medical needs bring op...

Dr Jay Mei from Antengene tells us how the Asia Pacific region is opening up to innovative pharma companies, and gives tips for companies navigating this enormous market.

Views & Analysis

“A long way to go” for digital health reimbursement

A recent analysis delves into the challenges companies face in getting digital health technologies reimbursed and presents recommendations for how these products can find a smoother path to

Views & Analysis

Time for a NICE change

The National Institute for Health and Care Excellence (NICE) is world-renowned for their work assessing the clinical and cost-effectiveness of new treatments.

Views & Analysis

Rethinking access barriers to innovation

Market access issues don’t stop once a product has passed HTA – and this is especially true for disruptive therapies like ATMPs.

Views & Analysis

Global impact: How regulatory affairs is shaping development of cutting-edge pharma innovation

AI meets RWE: The future of drug assessment?

Savana’s Dr Ignacio Medrano explains how machine learning and natural language processing technology is opening up huge amounts of previously-inaccessible real-world evidence (RWE) for phar

Views & Analysis